Familial gynecomastia with increased extraglandular aromatization of plasma carbon19-steroids.
نویسندگان
چکیده
منابع مشابه
Familial Gynecomastia with Increased Extraglandular Aromatization
We evaluated a family in which gynecomastia occurred in five males in two generations. In each affected subject, gynecomastia and male sexual maturation began at an early age. The ratio of the concentration of plasma estradiol-17#6 to that of plasma testosterone was elevated in each affected subject. In the three siblings with gynecomastia, the transfer constant of conversion of androstenedione...
متن کاملBiological aromatization of steroids.
The conversion of androgenic steroids to the phenolic estrogens by mammalian tissue has been well documented. The reaction has been reported in relatively low yield, in vitro with ovarian and placental slices (l-3), and in viva after the administration of androgens to various species including man (4, 5). The present report describes the conversion of androgens to estrogens in high yield by a s...
متن کاملMicrobial aromatization of steroids into equilin.
This report describes the bioconversion of 19-hydroxy-androsta-4, 7-diene-3, 17-dione into equilin with Nocardia rubra. Through mutation and improvement of medium and of conditions, the bioconversion could be improved to yield 40% equilin for a substrate concentration of 1 g/liter. Aromatization of several other 19-hydroxy and 19-nor substrates of the androstene series is reported, and the infl...
متن کاملPlasma phthalate levels in pubertal gynecomastia.
OBJECTIVE Several untoward health effects of phthalates, which are a group of industrial chemicals with many commercial uses including personal-care products and plastic materials, have been defined. The most commonly used, di-(2-ethylhexyl)-phthalate (DEHP), is known to have antiandrogenic or estrogenic effects or both. Mono-(2-ethylhexyl)-phthalate (MEHP) is the main metabolite of DEHP. In th...
متن کاملFABP4 plasma levels are increased in familial combined hyperlipidemia.
The lipid profile of familial combined hyperlipidemia (FCHL) shares some characteristics with atherogenic dyslipidemia seen in diabetes, metabolic syndrome, and obesity. Adipocyte fatty acid-binding protein 4 (FABP4) appears to be a determinant of atherogenic dyslipidemia. We examined relationships between FABP4 plasma concentrations, dyslipidemia, and metabolic variables in patients with FCHL....
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Clinical Investigation
سال: 1985
ISSN: 0021-9738
DOI: 10.1172/jci111888